Glucose anhydrous 20g / Sodium chloride 3.5g / Sodium citrate 2.9g oral powder sachets
Requires a prescription from a doctor or prescriber
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Yellow Card
Report side effects (MHRA)
Drug safety updates
MHRA alerts for Glucose + Sodium chloride + Sodium citrate
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
MHRA licensed products
View all licensed products for Glucose + Sodium chloride + Sodium citrate on the MHRA register
Oral Rehydration Salts potassium free powder sachets (Queens Hospital Burton formula)
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 4 · Randomised trials: 2 · 1937–2026
Showing the 50 most relevant studies, sorted by most relevant.
Hermann Koepsell
Pflügers Archiv - European Journal of Physiology, 2020
- Alzheimer Disease
- Brain
- Carbohydrate Metabolism, Inborn Errors
Roger W. Hunter, Curtis C. Hughey, Louise Lantier, et al.
Nature Medicine, 2018
- Adenosine Monophosphate
- Aminoimidazole Carboxamide
- Base Sequence
Michael S. Stone, Lisa Martyn, Connie M. Weaver
Nutrients, 2016
- Models, Biological
- Cardiovascular Diseases
- Diabetes Mellitus, Type 2
Muhammad Suleman, Sumera Yasmin, Maria Rasul, et al.
PLoS ONE, 2018
- Bacteria
- Biological Transport
- Phosphates
Tsuang FY, Wu YL, Chan KC, et al.
2026
- Lumbar Vertebrae
- Fluid Therapy
- Ringer's Lactate
IntroductionIntravenous crystalloid fluid infusion is a mandatory nutritional intervention received by surgical patients. Crystalloids vary in the pH value and electrolyte balance when administered; these effects directly alter plasma and urine compositions and can considerably affect the patient's intraoperative metabolism.MethodsThis randomized controlled study compared 0.9% saline solution and lactated Ringer's solution in terms of intraoperative metabolism among 56 patients undergoing lumbar spinal surgery. Blood and urine samples were obtained before and after surgery for arterial blood gas analysis and untargeted metabolomic analysis using liquid chromatography-mass spectrometry.ResultsPatients receiving 0.9% saline developed hyperchloremic acidosis and exhibited higher postoperative plasma concentrations of sodium (interaction P = 0.008) and glucose (interaction P = 0.034). They also required higher intraoperative norepinephrine doses (18 [0-43] μg vs. 0 [0-5] μg; P P = .051); significantly higher oxaloacetate concentrations (interaction P = .015), which may indicate less intraoperative gluconeogenesis (interaction P = .015); lower leucine degradation metabolite concentration, namely hydroxyisocaproic acid (interaction P = .055); and an attenuated decline in anti-inflammatory phospholipid breakdown metabolite, namely 15-ketoeicosatetraenoic acid (interaction P = .063). By contrast, patients receiving 0.9% saline solution exhibited unfavorable metabolism in urine indicated by reduced excretion of citric acid and creatine, which correlated with reduced glomerular filtration rates.ConclusionsThe administration of lactated Ringer's solution may facilitate more favorable intraoperative metabolic profiles than the administration of 0.9% saline solution during lumbar spinal surgery.
Abstract licence: CC BY-NC
Li P, Li M, Yin W, et al.
2025
- Calcium
- Citric Acid
- Anticoagulants
The UBI Study Group, Biagio Di Iorio, Antonio Bellasi, et al.
Journal of Nephrology, 2019
- Acidosis
- Glomerular Filtration Rate
- Italy
Jacek Baj, Wojciech Flieger, Grzegorz Teresiński, et al.
Journal of Clinical Medicine, 2020
S. Hestrin, M. Schramm
Biochemical Journal, 1954
- Acetobacter
- Gluconacetobacter xylinus
- Carbohydrate Metabolism
Ralph A. DeFronzo, Colin R. Cooke, R Andres, et al.
Journal of Clinical Investigation, 1975
- Aldosterone
- Aminohippuric Acids
- Blood Glucose
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.